Curis (CRIS) Current Leases (2019 - 2026)
Curis' (CRIS) quarterly Current Leases came in at $1.2 million in Q1 2026, down 5.53% YoY from $1.3 million in Q1 2025, and up 3.28% on a QoQ basis from $1.2 million in Q4 2025.
Curis (CRIS) Current Leases (2019 - 2026) Analysis & Trends
Curis (CRIS) has 8 years of Current Leases data on file, last reported at $1.2 million in Q1 2026.
- Quarterly Current Leases fell 5.53% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 5.53% YoY) and the FY2025 annual result came in at $1.2 million, down 10.93% from the prior year.
- Current Leases grew to $1.2 million in Q1 2026, from $1.2 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.3 million in Q1 2024 to a low of $824000.0 in Q1 2022.
- A 5-year average of $1.2 million and a median of $1.2 million in 2026 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases soared 68.51% — and 2025, when it retreated 10.93%.
- Tracing CRIS's Current Leases over 5 years: stood at $1.1 million in 2022, then climbed by 14.37% to $1.3 million in 2023, then rose by 2.38% to $1.3 million in 2024, then dropped by 10.93% to $1.2 million in 2025, then advanced by 3.28% to $1.2 million in 2026.
- The last three Current Leases figures came in at $1.2 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - | 1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 1.27 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.31 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Mar 31, 2022 | 824,000.00 |
| Dec 31, 2021 | 682,000.00 |
| Sep 30, 2021 | 657,000.00 |
| Jun 30, 2021 | 632,000.00 |